ClinicalTrials.Veeva

Menu

Comparative Evaluation of Contact Lens Centering of DAILIES® AquaComfort Plus® Versus 1-DAY ACUVUE® MOIST® in Japan

Alcon logo

Alcon

Status

Completed

Conditions

Myopia
Refractive Error
Myopic Astigmatism

Treatments

Device: Nelfilcon A contact lenses
Device: Etafilcon A contact lenses

Study type

Interventional

Funder types

Industry

Identifiers

NCT02103309
M-13-050

Details and patient eligibility

About

The purpose of this study is to evaluate lens centration and subjective impressions of DAILIES® AquaComfort Plus® (DACP) lenses compared to 1-DAY ACUVUE® MOIST® (1DAM) lenses in ball sports players.

Enrollment

42 patients

Sex

All

Ages

18 to 29 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Those who can understand the clinical study objectives and provide written informed consent. Legal representative or parental consent required if under age 20
  • Those who regularly wear soft contact lenses in both eyes for a minimum of 8 hours per day and 5 days per week
  • Those who play ball sports at least 1 day per week
  • Those who need vision correction because of myopia or mild myopic astigmatism, who are eligible for use of the study device, and who can attain a visual acuity of at least 1.0 with correction
  • Other protocol-defined inclusion criteria may apply

Exclusion criteria

  • Those who regularly wear the study device
  • Those who require ocular treatment with eye drops
  • Those who have a condition contraindicating soft contact lens wear, such as eye irritation
  • Those who have had ocular disorder or ocular surgery that may affect soft contact lens wear within 3 months before the start of the study
  • Those who are participating in another clinical study or research or have a plan of such participation during the present study
  • Women who are pregnant or intend to become pregnant during the study
  • Other protocol-defined exclusion criteria may apply

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

42 participants in 2 patient groups

DACP, then 1DAM
Other group
Description:
Nelfilcon A contact lenses worn first, then etafilcon A contact lenses worn second. Each product worn bilaterally (in both eyes) for 1 week in a daily disposable mode.
Treatment:
Device: Etafilcon A contact lenses
Device: Nelfilcon A contact lenses
1DAM, then DACP
Other group
Description:
Etafilcon A contact lenses worn first, then nelfilcon A contact lenses worn second. Each product worn bilaterally (in both eyes) for 1 week in a daily disposable mode.
Treatment:
Device: Etafilcon A contact lenses
Device: Nelfilcon A contact lenses

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems